Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Opioid Use Disorder
Interventions
OTHER

Embodied conversational agent (ECA)

The app with the ECA will be provided.

OTHER

Technical support

Technical support will include assistance downloading and setting up the app on the participant's phone, walking them through a brief demonstration, and answering any questions the participant has about how to use the app.

OTHER

Additional ECA messages

Weekly text messages will be provided reminding participants to use the app on behalf of OBAT clinical staff.

OTHER

Additional incentives

Additional incentives will be provided after logging into the app for 20 days followed by monthly lotteries for those who log in 15 days per month

Trial Locations (1)

02118

Office-Based Addiction Treatment (OBAT) Clinic, BMC, Boston

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Boston Medical Center

OTHER